Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-26-003732·BlackRock, Inc.
Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Common Stock · CUSIP: M96088105
Event date: 2026-09-30
- Filing-level shares
- 3,058,648
- Percent of class
- 6.3%
- BlackRock, Inc.
Shares: 3,058,648 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-003732
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 27, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership